Stock CGEN COMPUGEN LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Compugen Ltd.

Equities

CGEN

IL0010852080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.17 USD -0.91% Intraday chart for Compugen Ltd. -11.07% +9.60%
May. 30 Compugen Ltd. to Receive Milestone Payment from Astrazeneca Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig CI
May. 20 Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating MT

Evolution of the average Target Price on Compugen Ltd.

Price target over the last 5 years

History of analyst recommendation changes

015a9a9b5fcfa7f3383b747b1512be1._goXhQT5_X1iuCHInrVOjdhrnsLTxOH0Sxzxcmcm4SM.jTNO60-1zA0SyECK3fsG3pIjz4m6s9ezE0TJQQhxohWyf23sXJK2SxT6ZA~1e16068a2f3dc492b18460cdfdb8336e

Analyst Recommendations on Compugen Ltd.

Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating MT
Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon MT
Oppenheimer Adjusts Compugen's Price Target to $7 From $8, Maintains Outperform Rating MT
Jefferies Downgrades Compugen to Underperform From Hold, Lowers Price Target to $0.50 from $2 MT
EF Hutton Initiates Compugen at Buy With $13 Price Target MT
Oppenheimer Adjusts Compugen PT to $8 From $12, Updates Model to Reflect Evolving Development Strategy; Maintains Outperform Rating MT
Truist Securities Adjusts Compugen's Price Target to $4 From $14, Reiterates Buy Rating MT
JMP Securities Adjusts Price Target on Compugen to $4 From $8, Maintains Market Outperform Rating MT
Oppenheimer Adjusts Compugen Price Target to $12 From $14, Maintains Outperform Rating MT
Stifel Adjusts Compugen's Price Target to $5 From $12, Reiterates Buy Rating MT
Jefferies Downgrades Compugen to Hold From Buy; Price Target is $2 MT
SVB Leerink Adjusts Compugen's Price Target to $9 from $16, Maintains Outperform Rating MT
Oppenheimer Adjusts Compugen's Price Target to $14 From $17, Maintains Outperform Rating MT
Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating MT
COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.17 USD
Average target price
5 USD
Spread / Average Target
+130.41%
High Price Target
7 USD
Spread / Highest target
+222.58%
Low Price Target
4 USD
Spread / Lowest Target
+84.33%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Compugen Ltd.

Truist Securities
Oppenheimer
Jefferies & Co.
EF Hutton
JMP Securities
Stifel Nicolaus
SVB Leerink

Ratings for Compugen Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CGEN Stock
  4. Consensus Compugen Ltd.